Stocktoria
BOSTON SCIENTIFIC CORP BSX
BOSTON SCIENTIFIC CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B | $9.9B | $10.7B | $9.8B | $9.0B | $9.1B |
| Gross profit | $13.9B | $11.5B | $9.9B | $8.7B | $8.2B | $6.4B | $7.6B | $7.0B | $6.5B | $6.0B |
| SG&A expense | $6.9B | $6.0B | $5.2B | $4.5B | $4.4B | $3.8B | $3.9B | $3.6B | $3.3B | $3.1B |
| Operating income | $3.6B | $2.6B | $2.3B | $1.6B | $1.2B | -$80.0M | $1.5B | $1.5B | $1.3B | $447.0M |
| Interest expense | $349.0M | $305.0M | $265.0M | $470.0M | $341.0M | $361.0M | $473.0M | $241.0M | $229.0M | $233.0M |
| Income tax | $493.0M | $436.0M | $393.0M | $443.0M | $36.0M | $2.0M | -$4.0B | -$249.0M | $828.0M | -$170.0M |
| Operating cash flow | $4.5B | $3.4B | $2.5B | $1.5B | $1.9B | $1.5B | $1.8B | $310.0M | $1.4B | $1.2B |
| Free cash flow | $3.7B | $2.6B | $1.8B | $938.0M | $1.3B | $1.1B | $1.4B | -$6.0M | $1.1B | $806.0M |
| Cash & equivalents | $2.0B | $414.0M | $865.0M | $928.0M | $1.9B | $1.7B | $217.0M | $146.0M | $188.0M | $196.0M |
| Inventory | $2.9B | $2.8B | $2.5B | $1.9B | $1.6B | $1.4B | $1.6B | $1.2B | $1.1B | $955.0M |
| Total assets | $43.7B | $39.4B | $35.1B | $32.5B | $32.2B | $30.8B | $30.6B | $21.0B | $19.0B | $18.1B |
| Shareholders' equity | $24.5B | $22.0B | $19.5B | $17.6B | $16.6B | $15.3B | $13.9B | $8.7B | $7.0B | $6.7B |
| EPS (diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | $-0.08 | $3.33 | $1.19 | $0.08 | $0.25 |
Growth · year-over-year · Revenue CAGR 9.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +19.9% | +17.6% | +12.3% | +6.7% | +19.9% | -7.7% | +9.3% | +8.6% | -0.3% | +12.5% |
| EPS growth | +55.2% | +16.8% | +137.8% | -34.8% | — | -102.4% | +179.8% | +1387.5% | -68.0% | — |
| Free cash flow growth | +38.3% | +47.6% | +91.0% | -28.7% | +16.3% | -17.7% | — | -100.5% | +37.3% | +81.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.